相关实验视频

Updated: Jan 16, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Published on: June 23, 2013

糖尿病血管并发症中的巨细胞两极分化:机制性见解和治疗点

Liyuan Cao¹, Lu Ding², Qinjing Xia¹

¹Department of Endocrinology, The First Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130021, Jilin, China.

Journal of translational medicine

|October 4, 2025

概括

2型糖尿病会导致慢性炎症,影响血管. 糖尿病中的巨细胞两极分化会影响血管并发症,新的药物针对这种途径进行潜在的治疗.

科学领域:

免疫学免疫学免疫学
内分泌学在内分泌学.
血管生物学血管生物学

背景情况:

2型糖尿病 (T2DM) 是一种慢性代谢疾病,以高血糖和炎症为标志.
慢性炎症是由巨细胞等免疫细胞驱动的,在T2DM中加剧了宏血管和微血管并发症.
巨细胞两极分化是糖尿病环境中的一个关键过程,影响血管损伤的进展和解决.

研究的目的:

审查糖尿病血管并发症中的巨细胞两极化机制.
阐明将代谢功能障碍和巨细胞两极分化联系在一起的信号通路.
总结目前的策略和新的治疗目标,以调节糖尿病中巨细胞两极分化.

主要方法:

文献综述专注于糖尿病中的巨细胞两极分化.
对参与糖尿病血管并发症的信号通路的分析.
针对巨细胞两极分化的药理方法的总结.

主要成果:

巨细胞两极分化是驱动糖尿病血管并发症的炎症过程的核心.
糖尿病的代谢功能障碍显著影响巨细胞的表型和功能.
新兴的药理学策略旨在调节巨细胞两极分化以减轻血管损伤.

结论:

准巨细胞两极分化为治疗糖尿病血管并发症提供了一个有希望的治疗途径.
了解新陈代谢和巨细胞功能之间的相互作用对于开发有效的治疗方法至关重要.
调节巨细胞两极分化可能提供新的策略来预防或延迟与糖尿病相关的血管疾病进展.

关键词:

糖尿病血管并发症糖尿病血管并发症在M1极化巨细胞.在M2极化巨细胞.巨细胞的两极分化巨细胞是什么?巨细胞是什么?治疗方法治疗方法

更多相关视频

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis

Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis

Published on: November 28, 2015

相关概念视频

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Inflammation

Inflammation